Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boehringer ingelheim
4
×
life sciences
national blog main
boston blog main
boston top stories
cancer
clinical trials
eli lilly
indiana blog main
indiana top stories
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
merck
moderna
national
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
renaissance capital
seattle blog main
seattle top stories
texas blog main
texas top stories
abbvie
acceleron pharma
acid sphingomyelinase deficiency
aimmune therapeutics
What
companies
4
×
bio
life
roundup
science
week
abandoning
ago
approved
arena’s
baggage
black
bounty
cancer
cig
combo
comeback
continue
corner
cuts
dating
deal
deals
debut
delivered
development
diamond
diamond’s
dicerna
expressing
free
game
gets
happening
immunotherapies
indication
interference
ipo
kgaa
leading
Language
unset
Current search:
biotech
×
companies
×
" boehringer ingelheim "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M